Selected research
Market Structure
Global Antidepressants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Antidepressants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Antidepressants include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Antidepressants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Antidepressants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Antidepressants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antidepressants market size, projected growth trends, production technologies, key applications, and end-use industries.
Antidepressants Segment by Company
Bristol-Myers Squibb Company
H Lundbeck
Sun Pharmaceuticals
Astrazeneca
GlaxoSmithKline
Pfizer Inc.
Eli Lilly and Company
Merck
Johnson & Johnson
Sanofi
Antidepressants Segment by Type
Benzodiazepines
Monoamine Oxidase Inhibitors
Antipsychotics
Tricyclic Antidepressants
Novel Agents
Selective Norepinephrine Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
Antidepressants Segment by Application
Hospitals
Clinics
Other
Antidepressants Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Antidepressants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Benzodiazepines
- Monoamine Oxidase Inhibitors
- Antipsychotics
- Tricyclic Antidepressants
- Novel Agents
- Selective Norepinephrine Reuptake Inhibitors
- Selective Serotonin Reuptake Inhibitors
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Bristol-Myers Squibb Company
- H Lundbeck
- Sun Pharmaceuticals
- Astrazeneca
- GlaxoSmithKline
- Pfizer Inc.
- Eli Lilly and Company
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Antidepressants Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Antidepressants Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Antidepressants Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Antidepressants Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Antidepressants Market Dynamics
- 2.1 Antidepressants Industry Trends
- 2.2 Antidepressants Industry Drivers
- 2.3 Antidepressants Industry Opportunities and Challenges
- 2.4 Antidepressants Industry Restraints
3 Antidepressants Market by Manufacturers
- 3.1 Global Antidepressants Revenue by Manufacturers (2021-2026)
- 3.2 Global Antidepressants Sales by Manufacturers (2021-2026)
- 3.3 Global Antidepressants Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Antidepressants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antidepressants Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Antidepressants Manufacturers, Product Type & Application
- 3.7 Global Antidepressants Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antidepressants Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antidepressants Players Market Share by Revenue in 2025
- 3.8.3 2025 Antidepressants Tier 1, Tier 2, and Tier 3
4 Antidepressants Market by Type
- 4.1 Antidepressants Type Introduction
- 4.1.1 Benzodiazepines
- 4.1.2 Monoamine Oxidase Inhibitors
- 4.1.3 Antipsychotics
- 4.1.4 Tricyclic Antidepressants
- 4.1.5 Novel Agents
- 4.1.6 Selective Norepinephrine Reuptake Inhibitors
- 4.1.7 Selective Serotonin Reuptake Inhibitors
- 4.2 Global Antidepressants Sales by Type
- 4.2.1 Global Antidepressants Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Antidepressants Sales by Type (2021-2032)
- 4.2.3 Global Antidepressants Sales Market Share by Type (2021-2032)
- 4.3 Global Antidepressants Revenue by Type
- 4.3.1 Global Antidepressants Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Antidepressants Revenue by Type (2021-2032)
- 4.3.3 Global Antidepressants Revenue Market Share by Type (2021-2032)
5 Antidepressants Market by Application
- 5.1 Antidepressants Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Antidepressants Sales by Application
- 5.2.1 Global Antidepressants Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Antidepressants Sales by Application (2021-2032)
- 5.2.3 Global Antidepressants Sales Market Share by Application (2021-2032)
- 5.3 Global Antidepressants Revenue by Application
- 5.3.1 Global Antidepressants Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Antidepressants Revenue by Application (2021-2032)
- 5.3.3 Global Antidepressants Revenue Market Share by Application (2021-2032)
6 Global Antidepressants Sales by Region
- 6.1 Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Antidepressants Sales by Region (2021-2032)
- 6.2.1 Global Antidepressants Sales by Region (2021-2026)
- 6.2.2 Global Antidepressants Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Antidepressants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Antidepressants Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Antidepressants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Antidepressants Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Antidepressants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Antidepressants Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Antidepressants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Antidepressants Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Antidepressants Revenue by Region
- 7.1 Global Antidepressants Revenue by Region
- 7.1.1 Global Antidepressants Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Antidepressants Revenue by Region (2021-2026)
- 7.1.3 Global Antidepressants Revenue by Region (2027-2032)
- 7.1.4 Global Antidepressants Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Antidepressants Revenue (2021-2032)
- 7.2.2 North America Antidepressants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Antidepressants Revenue (2021-2032)
- 7.3.2 Europe Antidepressants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Antidepressants Revenue (2021-2032)
- 7.4.2 Asia-Pacific Antidepressants Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Antidepressants Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Antidepressants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bristol-Myers Squibb Company
- 8.1.1 Bristol-Myers Squibb Company Company Information
- 8.1.2 Bristol-Myers Squibb Company Business Overview
- 8.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
- 8.1.5 Bristol-Myers Squibb Company Recent Developments
- 8.2 H Lundbeck
- 8.2.1 H Lundbeck Company Information
- 8.2.2 H Lundbeck Business Overview
- 8.2.3 H Lundbeck Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 H Lundbeck Antidepressants Product Portfolio
- 8.2.5 H Lundbeck Recent Developments
- 8.3 Sun Pharmaceuticals
- 8.3.1 Sun Pharmaceuticals Company Information
- 8.3.2 Sun Pharmaceuticals Business Overview
- 8.3.3 Sun Pharmaceuticals Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
- 8.3.5 Sun Pharmaceuticals Recent Developments
- 8.4 Astrazeneca
- 8.4.1 Astrazeneca Company Information
- 8.4.2 Astrazeneca Business Overview
- 8.4.3 Astrazeneca Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Astrazeneca Antidepressants Product Portfolio
- 8.4.5 Astrazeneca Recent Developments
- 8.5 GlaxoSmithKline
- 8.5.1 GlaxoSmithKline Company Information
- 8.5.2 GlaxoSmithKline Business Overview
- 8.5.3 GlaxoSmithKline Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 GlaxoSmithKline Antidepressants Product Portfolio
- 8.5.5 GlaxoSmithKline Recent Developments
- 8.6 Pfizer Inc.
- 8.6.1 Pfizer Inc. Company Information
- 8.6.2 Pfizer Inc. Business Overview
- 8.6.3 Pfizer Inc. Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pfizer Inc. Antidepressants Product Portfolio
- 8.6.5 Pfizer Inc. Recent Developments
- 8.7 Eli Lilly and Company
- 8.7.1 Eli Lilly and Company Company Information
- 8.7.2 Eli Lilly and Company Business Overview
- 8.7.3 Eli Lilly and Company Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Eli Lilly and Company Antidepressants Product Portfolio
- 8.7.5 Eli Lilly and Company Recent Developments
- 8.8 Merck
- 8.8.1 Merck Company Information
- 8.8.2 Merck Business Overview
- 8.8.3 Merck Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Merck Antidepressants Product Portfolio
- 8.8.5 Merck Recent Developments
- 8.9 Johnson & Johnson
- 8.9.1 Johnson & Johnson Company Information
- 8.9.2 Johnson & Johnson Business Overview
- 8.9.3 Johnson & Johnson Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Johnson & Johnson Antidepressants Product Portfolio
- 8.9.5 Johnson & Johnson Recent Developments
- 8.10 Sanofi
- 8.10.1 Sanofi Company Information
- 8.10.2 Sanofi Business Overview
- 8.10.3 Sanofi Antidepressants Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sanofi Antidepressants Product Portfolio
- 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Antidepressants Value Chain Analysis
- 9.1.1 Antidepressants Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Antidepressants Production Mode & Process
- 9.2 Antidepressants Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Antidepressants Distributors
- 9.2.3 Antidepressants Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst